Ema gives green light to Pfizer vaccine for 5-11 year olds. Soon, the vaccine will be available in the EU and also in Italy. Among the experts, there are those who welcome today’s decision with doubts and perplexities. The position of Professor Andrea Crisanti stands out. “I would have waited a while longer to decide,” says the virologist. Yesterday it was the World Health Organization (WHO) that expressed itself with a provisional declaration that, while recognizing the safety and efficacy of the vaccine for children and a favorable risk-benefit ratio, it had pointed out that at this stage immunizing children is less urgent and priority over covering the frail and the elderly, and raising coverage in poor countries. “I do not make it a matter of priority – says Crisanti – I am convinced, and I repeat, that there are no problems in vaccinating children. Only, I do not think that the data available are sufficient to justify this decision. I would have waited for a The study in question concerns 3 thousand children “. Maria Rita Gismondo, director of the Laboratory of clinical microbiology, virology and bio-emergency diagnostics at the Sacco hospital in Milan, is on a similar line. “At the moment there are not enough data to be able to support the choice of the anti-Covid vaccine in the age group 5-11 years, also because there are no valid data on the risk-benefit ratio. This is obviously true for children in good health. Health. Different speech for the frail, because all the frail, of any age, should be vaccinated “, he says.” Moreover for children there is no problem of being a reservoir of infection for grandparents, for adults “, observes the expert, above all because “adults and grandparents tend to be vaccinated already. Indeed – she reiterates – they should be compulsorily vaccinated”.